CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1/HSP90β complex
Open Access
- 1 September 2023
- journal article
- research article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 55 (9) , 2051-2066
Abstract
The identification of key regulatory factors that control osteoclastogenesis is important. Accumulating evidence indicates that circular RNAs (circRNAs) are discrete functional entities. However, the complexities of circRNA expression as well as the extent of their regulatory functions during osteoclastogenesis have yet to be revealed. Here, based on circular RNA sequencing data, we identified a circular RNA, circFam190a, as a critical regulator of osteoclast differentiation and function. During osteoclastogenesis, circFam190a is significantly upregulated. In vitro, circFam190a enhanced osteoclast formation and function. In vivo, overexpression of circFam190a induced significant bone loss, while knockdown of circFam190a prevented pathological bone loss in an ovariectomized (OVX) mouse osteoporosis model. Mechanistically, our data suggest that circFam90a enhances the binding of AKT1 and HSP90β, promoting AKT1 stability. Altogether, our findings highlight the critical role of circFam190a as a positive regulator of osteoclastogenesis, and targeting circFam190a might be a promising therapeutic strategy for treating pathological bone loss.Keywords
Funding Information
- National Natural Science Foundation of China (82072408, 82102601, U19A2008)
- China Postdoctoral Science Foundation (2020TQ0310)
- Natural Science Foundation of Anhui Province (2008085QH363)
This publication has 70 references indexed in Scilit:
- Disruption of PH–kinase domain interactions leads to oncogenic activation of AKT in human cancersProceedings of the National Academy of Sciences, 2012
- Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseasesRheumatology, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Osteoporosis: now and the futureThe Lancet, 2011
- Targeting PI3K/Akt/HSP90 Signaling Sensitizes Gastric Cancer Cells to Deoxycholate-Induced ApoptosisDigestive Diseases and Sciences, 2010
- Akt1 in Osteoblasts and Osteoclasts Controls Bone RemodelingPLOS ONE, 2007
- Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiationCellular Signalling, 2005
- Hsp90–Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosisOncogene, 2005
- Osteoclast differentiation and activationNature, 2003
- Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 FunctionJournal of Biological Chemistry, 2002